 |
|
Extended Hepatectomy in Patients With Hepatobiliary Malignancies With and Without Preoperative Portal Vein Embolization
Eddie K. Abdalla, MD;
Carlton C. Barnett, MD;
Dorota Doherty, PhD;
Steven A. Curley, MD;
Jean-Nicolas Vauthey, MD
Arch Surg. 2002;137:675-681.
Hypothesis Preoperative portal vein embolization (PVE) allows potentially curative hepatic resection without additional morbidity or mortality in patients with hepatobiliary malignancies who are marginal candidates for resection based on small liver remnant size.
Design A retrospective review of a consecutive series of patients in a multi-institutional database who underwent extended hepatectomy.
Setting University-based referral centers.
Patients Forty-two patients underwent preoperative determination of the future liver remnant (FLR) volume before extended hepatectomy ( 5 segments) for hepatobiliary malignancy without chronic underlying liver disease. Patients were stratified by treatment with or without preoperative PVE.
Intervention Preoperative percutaneous PVE.
Main Outcome Measures Clinical characteristics, FLR volume, operative morbidity, and survival.
Results There was no difference between the groups that did and did not undergo PVE for the number of tumors, tumor size, estimated blood loss, duration of the operation, complexity of resection, or surgical margins. The FLR at presentation was significantly smaller in patients who underwent PVE than in patients who did not undergo PVE (18% vs 23%; P<.001). After PVE, FLR volumes increased significantly (P = .003); preoperative FLR volumes were similar in both groups (patients who underwent PVE, 25%; and patients who did not undergo PVE, 23%). There was no perioperative mortality and no statistical difference in the incidence of perioperative complications between those who did and those who did not undergo PVE (5 [28%] of 18 patients vs 5 [21%] of 24 patients). The overall 3-year survival was 65% and the median survival duration was equivalent in the 2 groups (40 vs 52 months for those who did vs those who did not undergo PVE).
Conclusion Portal vein embolization enables safe and potentially curative extended hepatectomy in a subset of patients who would otherwise be marginal candidates for resection based on a small liver remnant size.
From the Departments of Surgical Oncology (Drs Abdalla, Barnett, Curley, and Vauthey) and Biostatistics (Dr Doherty), The University of Texas MD Anderson Cancer Center, Houston.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Liver Regeneration at Day 7 after Right Hepatectomy: Global and Segmental Volumetric Analysis by Using CT
Zappa et al.
Radiology 2009;252:426-432.
ABSTRACT
| FULL TEXT
Liver Regeneration at Day 7 after Right Hepatectomy: Global and Segmental Volumetric Analysis by Using CT
Zappa et al.
Radiology 2009;0:2523080922.
ABSTRACT
| FULL TEXT
Expanding Criteria for Resectability of Colorectal Liver Metastases
Pawlik et al.
The Oncologist 2008;13:51-64.
ABSTRACT
| FULL TEXT
Presurgical Chemotherapy in Patients Being Considered for Liver Resection
Kemeny
The Oncologist 2007;12:825-839.
ABSTRACT
| FULL TEXT
Downstaging or Downsizing: Time for a New Staging System in Advanced Colorectal Cancer?
Poston et al.
JCO 2006;24:2702-2706.
FULL TEXT
Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy.
Beal et al.
Br. J. Radiol. 2006;79:473-478.
ABSTRACT
| FULL TEXT
Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases
Vauthey et al.
JCO 2006;24:2065-2072.
ABSTRACT
| FULL TEXT
Solitary Colorectal Liver Metastasis: Resection Determines Outcome
Aloia et al.
Arch Surg 2006;141:460-467.
ABSTRACT
| FULL TEXT
One Surgeon's Unabashedly Biased View on Liver Resection
Curley
JCO 2005;23:8286-8288.
FULL TEXT
Diagnosis and Treatment of Cholangiocarcinoma
Anderson et al.
The Oncologist 2004;9:43-57.
ABSTRACT
| FULL TEXT
|
